News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Julia Lai-Kwon Previews Presentation at COSA24 on PROs for Symptom Monitoring
Julia Lai-Kwon/X
Nov 12, 2024, 18:17

Julia Lai-Kwon Previews Presentation at COSA24 on PROs for Symptom Monitoring

Julia Lai-Kwon, Medical Oncologist and PhD candidate at the Peter MacCallum Cancer Centre, posted on X:

“Looking forward to presenting at COSA24 The Clinical Oncology Society of Australia (COSA)! Our session will explore using PROs for symptom monitoring (and what we can learn from home and abroad), survivorship care, and AI applications. See you there!”

Dr. Julia Lai-Kwon is a Medical Oncologist and PhD candidate at the Peter MacCallum Cancer Centre. Her clinical interests encompass melanoma and other cutaneous malignancies. Dr. Lai-Kwon specializes in quality of life research, survivorship, and patient-reported outcomes, contributing to a deeper understanding of the patient experience and improving treatment approaches.

AI applications cancer cancer care cancer survivorship clinical research COSA24 Healthcare Innovation healthcare presentation Healthcare Technology Julia Lai-Kwon Medical Advancements OncoDaily Oncology patient reported outcomes PROS survivorship care symptom monitoring
Special Coverage
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus